Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform
Go back to Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform| Danaher Corp. (NYSE: DHR) | Delayed: 178.97 +0.78 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $178.19 | 52 Week High | $102.79 | |||
| Open | $179.07 | 52 Week Low | $75.71 | |||
| Day High | $181.71 | P/E | 47.10 | |||
| Day Low | $177.07 | EPS | $3.80 | |||
| Volume | 4,149,961 | |||||
